Hypothesis

The epigenetic age of the gut microbiome, not host cellular age, drives inflammaging and blood‑brain barrier (BBB) leakage that precedes cognitive decline. We propose that age‑associated shifts in microbial circadian rhythms alter the microbial DNA methylation clock, accelerating microbial epigenetic age. This advanced microbial epigenetic state reduces production of circadian‑timed short‑chain fatty acids (SCFAs) and secondary bile acids, leading to decreased activation of host G‑protein coupled receptors (FFAR2, TGR5) on endothelial and microglial cells. Consequently, NF‑κB signaling in microglia rises, tight‑junction proteins (claudin‑5, occludin) in the BBB are downregulated, and peripheral inflammatory cytokines enter the brain, amplifying neuroinflammation and accelerating brain aging.

Testable Predictions

1. In a longitudinal human cohort, baseline stool‑derived microbial epigenetic age will predict future increases in plasma IL‑6, CSF/serum albumin ratio (BBB permeability), and cognitive test scores, independent of host epigenetic age.
2. Experimental restoration of microbial circadian rhythms via time‑restricted feeding (TRF) in aged mice will reduce microbial epigenetic age, increase fecal SCFA and secondary bile acid concentrations, improve BBB integrity, and rescue memory performance.
3. Pharmacological activation of FFAR2 or TGR5 in aged mice with dysbiotic microbiomes will mimic the protective effects of TRF, lowering microglial NF‑κB activity and slowing cognitive decline, even without altering microbial epigenetic age.

Novel Mechanistic Insight

Microbial circadian regulators (e.g., NAP‑like proteins) directly modulate bacterial DNA methyltransferases, creating a feedback loop where host feeding times shape microbial methylation patterns. When this loop breaks with age, microbes lose the rhythmic release of metabolites that normally sustain host receptor signaling. The resulting metabolite deficit shifts endothelial and microglial cells from a quiescent to an activated state, providing a mechanistic link between microbial epigenetic age and inflammaging.

Falsifiability

If microbial epigenetic age shows no correlation with future BBB leakage or cognitive decline, or if TRF fails to modify microbial epigenetic age and downstream phenotypes despite robust adherence, the hypothesis would be refuted. Conversely, confirming the predicted relationships would support the notion that tracking and resetting the microbiome’s epigenetic clock is a viable strategy to mitigate brain aging.